BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

620 related articles for article (PubMed ID: 12133532)

  • 1. Protein kinase A-mediated phosphorylation of HERG potassium channels in a human cell line.
    Wei Z; Thomas D; Karle CA; Kathöfer S; Schenkel J; Kreye VA; Ficker E; Wible BA; Kiehn J
    Chin Med J (Engl); 2002 May; 115(5):668-76. PubMed ID: 12133532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletion of protein kinase A phosphorylation sites in the HERG potassium channel inhibits activation shift by protein kinase A.
    Thomas D; Zhang W; Karle CA; Kathöfer S; Schöls W; Kübler W; Kiehn J
    J Biol Chem; 1999 Sep; 274(39):27457-62. PubMed ID: 10488078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of HERG potassium channel activation by protein kinase C independent of direct phosphorylation of the channel protein.
    Thomas D; Zhang W; Wu K; Wimmer AB; Gut B; Wendt-Nordahl G; Kathöfer S; Kreye VA; Katus HA; Schoels W; Kiehn J; Karle CA
    Cardiovasc Res; 2003 Jul; 59(1):14-26. PubMed ID: 12829172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of rat erg1, erg2, erg3 and HERG K+ currents by thyrotropin-releasing hormone in anterior pituitary cells via the native signal cascade.
    Schledermann W; Wulfsen I; Schwarz JR; Bauer CK
    J Physiol; 2001 Apr; 532(Pt 1):143-63. PubMed ID: 11283231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Properties of HERG channels stably expressed in HEK 293 cells studied at physiological temperature.
    Zhou Z; Gong Q; Ye B; Fan Z; Makielski JC; Robertson GA; January CT
    Biophys J; 1998 Jan; 74(1):230-41. PubMed ID: 9449325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of HERG potassium channels by extracellular magnesium and quinidine.
    Po SS; Wang DW; Yang IC; Johnson JP; Nie L; Bennett PB
    J Cardiovasc Pharmacol; 1999 Feb; 33(2):181-5. PubMed ID: 10028924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High affinity open channel block by dofetilide of HERG expressed in a human cell line.
    Snyders DJ; Chaudhary A
    Mol Pharmacol; 1996 Jun; 49(6):949-55. PubMed ID: 8649354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular determinants of dofetilide block of HERG K+ channels.
    Ficker E; Jarolimek W; Kiehn J; Baumann A; Brown AM
    Circ Res; 1998 Feb; 82(3):386-95. PubMed ID: 9486667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Open channel block by KCB-328 [1-(2-amino-4-methanesulfonamidophenoxy)-2-[N-(3,4-dimethoxyphenethyl)-N-methylamino]ethane hydrochloride] of the heterologously expressed human ether-a-go-go-related gene K+ channels.
    Park JB; Choe H; Lee YK; Ha KC; Rhee KS; Ko JK; Joo CU; Chae SW; Kwak YG
    J Pharmacol Exp Ther; 2002 Jul; 302(1):314-9. PubMed ID: 12065732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-affinity blockade of human ether-a-go-go-related gene human cardiac potassium channels by the novel antiarrhythmic drug BRL-32872.
    Thomas D; Wendt-Nordahl G; Röckl K; Ficker E; Brown AM; Kiehn J
    J Pharmacol Exp Ther; 2001 May; 297(2):753-61. PubMed ID: 11303067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single HERG delayed rectifier K+ channels expressed in Xenopus oocytes.
    Zou A; Curran ME; Keating MT; Sanguinetti MC
    Am J Physiol; 1997 Mar; 272(3 Pt 2):H1309-14. PubMed ID: 9087606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular physiology and pharmacology of HERG. Single-channel currents and block by dofetilide.
    Kiehn J; Lacerda AE; Wible B; Brown AM
    Circulation; 1996 Nov; 94(10):2572-9. PubMed ID: 8921803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton and zinc effects on HERG currents.
    Anumonwo JM; Horta J; Delmar M; Taffet SM; Jalife J
    Biophys J; 1999 Jul; 77(1):282-98. PubMed ID: 10388757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetic modulation of HERG potassium channels by the volatile anesthetic halothane.
    Li J; Correa AM
    Anesthesiology; 2002 Oct; 97(4):921-30. PubMed ID: 12357160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered gating of HERG potassium channels by cobalt and lanthanum.
    Sanchez-Chapula JA; Sanguinetti MC
    Pflugers Arch; 2000 Jun; 440(2):264-74. PubMed ID: 10898527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antihistamine fexofenadine does not affect I(Kr) currents in a case report of drug-induced cardiac arrhythmia.
    Scherer CR; Lerche C; Decher N; Dennis AT; Maier P; Ficker E; Busch AE; Wollnik B; Steinmeyer K
    Br J Pharmacol; 2002 Nov; 137(6):892-900. PubMed ID: 12411421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mechanism for the proarrhythmic effects of cisapride (Propulsid): high affinity blockade of the human cardiac potassium channel HERG.
    Rampe D; Roy ML; Dennis A; Brown AM
    FEBS Lett; 1997 Nov; 417(1):28-32. PubMed ID: 9395068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of block and identification of the verapamil binding domain to HERG potassium channels.
    Zhang S; Zhou Z; Gong Q; Makielski JC; January CT
    Circ Res; 1999 May; 84(9):989-98. PubMed ID: 10325236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of HERG potassium channel current by the class 1a antiarrhythmic agent disopyramide.
    Paul AA; Witchel HJ; Hancox JC
    Biochem Biophys Res Commun; 2001 Feb; 280(5):1243-50. PubMed ID: 11162661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of S818L mutation in HERG C-terminus in LQT2. Modification of activation-deactivation gating properties.
    Nakajima T; Kurabayashi M; Ohyama Y; Kaneko Y; Furukawa T; Itoh T; Taniguchi Y; Tanaka T; Nakamura Y; Hiraoka M; Nagai R
    FEBS Lett; 2000 Sep; 481(2):197-203. PubMed ID: 10996323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.